Introducing Priced to Compound
Welcome to Priced to Compound, a new independent investment research publication. Our goal is to deliver research on great companies that we have strong conviction in owning.
Priced to Compound Foundations
Our principles are rooted in evaluating companies at their prices today and on their merits for tomorrow. We firmly believe that being patient on price is one of the most important components of buying companies. Mediocre returns are a function of either buying poor companies or buying good companies at bad prices. Buying at great prices gives us time to be patient and creates marginal advantages that compound over time.
What to Expect
Research will come in the form of monthly issues that cover individual companies we are prospecting, ongoing updates on companies under coverage, and a side of market commentary and industry research. We can confidently say that we will be wrong, and we will be honest about it when we are. Our goal isn’t to buy every bottom or sell every top, but to make informed judgments using the best information available and remain intellectually honest when reality unfolds differently than we expect.
There will be at least one publication a month, sometimes more, but our vision is to create high-signal research rooted in process and patience, not another daily or weekly newsletter.
A Final Note
If you’re interested in markets and investing in individual stocks, we hope you find our research insightful and supplemental to your own research process. If you are just learning about stocks and the market, we hope to be a place where you can find grounded, level-headed analysis. If this sounds like something you would be interested in, we would greatly appreciate it if you subscribe and follow for more.